Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Massachusetts, United States
Countries of investment
  • USA
Investment stages
  • Seed
Industries
  • Pharma
  • Diagnostics
  • Biotechnology
  • Health Tech
  • Digital Health
About
Cure Ventures creates innovative companies to eradicate diseases by providing the right level of human and financial capital. Focused on disruptive technologies for high unmet patient needs.
Min check size
$100K
Max check size
$2M
Fund size
NPS

Investment Thesis

Cure Ventures focuses on investing in early stage biotech and life sciences companies, particularly those developing groundbreaking therapies and medical innovations.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With a strong background in venture capital, the fund manager brings extensive experience across various sectors, including technology and healthcare. They have successfully completed over 20 investments, focusing on early-stage opportunities within emerging markets. Their strategic approach emphasizes a data-driven methodology, enabling informed decision-making and maximizing returns. Notable exits further highlight their ability to identify high-potential startups, showcasing a keen insight into market trends and dynamics.
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp